Officers at Martin Shkreli's company received huge raises, documents show | STAT
Former Turing Pharmaceuticals CEO Martin Shkreli claimed that the price increase for taxoplasmosis drug Daraprim was used to fund research for new drugs. But at Thursday's House Oversight and Government Reform Committee hearing on drug prices, committee chairman Jason Chaffetz argued the motivation was purely profit, citing giant salary increases for Turing employees. One employee was given a raise of 400%, from $160,000 per year to $800,000, according to documents reviewed in the hearing.
Telemedicine providers propose legislation in Mississippi | Mississippi Business Journal
It's been about six months since the Mississippi Medical Licensure Board said it would provide an economic impact statement linked to its proposed rules changes for telemedicine. Meantime, Teladoc, the nation's largest telemedicine provider, has introduced a set of rules of its own in a bill in the Legislature.
New York state to offer free Zika testing to pregnant travelers | New York Times
The state of New York will be offering free testing to pregnant women who have traveled to a Zika-afflicted country, even if they aren't showing any symptoms, Gov. Andrew Cuomo announced Thursday.
Companies form new alliance to target healthcare costs | Wall Street Journal
Twenty major companies covering roughly 4 million U.S. employees are establishing an alliance to aggregate and analyze data on employee healthcare costs and outcomes in an attempt to hold down rising costs oh employee health insurance.
Lab criticized as slow to act in fatal French drug trial | Reuters
An investigation into a French stage 1 drug trial that left one participant dead and five others hospitalized has found that the laboratory was slow to act when the first trial subject showed signs of illness, administering the drug to the five other patients the following day without alerting oversight officials or trial participants of the first illness.
